(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:69477 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GPHN mRNA CTD PMID:22079256 1,1-dichloroethene decreases expression ISO RGD:1331858 6480464 vinylidene chloride results in decreased expression of GPHN mRNA CTD PMID:26682919 1,2-dimethylhydrazine decreases expression ISO RGD:1331858 6480464 1, 2-Dimethylhydrazine results in decreased expression of GPHN mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPHN mRNA CTD PMID:21215274 , PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1331858 6480464 Tetrachlorodibenzodioxin affects the expression of GPHN mRNA CTD PMID:21570461 , PMID:24680724 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of GPHN mRNA CTD PMID:21346803 2-methylcholine affects expression ISO RGD:69477 6480464 beta-methylcholine affects the expression of GPHN mRNA CTD PMID:21179406 4,4'-sulfonyldiphenol decreases methylation ISO RGD:69477 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of GPHN gene CTD PMID:31601247 4,4'-sulfonyldiphenol multiple interactions ISO RGD:69477 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of GPHN gene CTD PMID:31601247 4-hydroxyphenyl retinamide decreases expression ISO RGD:1331858 6480464 Fenretinide results in decreased expression of GPHN mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine decreases methylation ISO RGD:1331858 6480464 Decitabine results in decreased methylation of GPHN gene CTD PMID:27923600 7,12-dimethyltetraphene decreases expression ISO RGD:1331858 6480464 9 more ... CTD PMID:32553695 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of GPHN mRNA CTD PMID:31881176 aflatoxin B1 affects expression ISO RGD:69477 6480464 Aflatoxin B1 affects the expression of GPHN protein CTD PMID:20106945 aflatoxin B1 increases methylation ISO RGD:69477 6480464 Aflatoxin B1 results in increased methylation of GPHN intron CTD PMID:30157460 aflatoxin B1 decreases methylation ISO RGD:69477 6480464 Aflatoxin B1 results in decreased methylation of GPHN gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1331858 6480464 Aflatoxin B1 results in increased expression of GPHN mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO RGD:69477 6480464 Tretinoin results in decreased expression of GPHN mRNA CTD PMID:33167477 aristolochic acid A decreases expression ISO RGD:69477 6480464 aristolochic acid I results in decreased expression of GPHN mRNA CTD PMID:33212167 arsenite(3-) multiple interactions ISO RGD:69477 6480464 arsenite inhibits the reaction [G3BP1 protein binds to GPHN protein], arsenite promotes the reaction [G3BP1 protein binds to GPHN mRNA] CTD PMID:32406909 atrazine decreases expression ISO RGD:69477 6480464 Atrazine results in decreased expression of GPHN mRNA CTD PMID:22378314 benzo[a]pyrene decreases expression ISO RGD:1331858 6480464 Benzo(a)pyrene metabolite results in decreased expression of GPHN mRNA, Benzo(a)pyrene results in decreased expression of GPHN mRNA CTD PMID:19770486 , PMID:32553695 benzo[a]pyrene increases methylation ISO RGD:69477 6480464 Benzo(a)pyrene results in increased methylation of GPHN promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:69477 6480464 Benzo(a)pyrene results in decreased expression of GPHN mRNA CTD PMID:20106945 more ... benzo[a]pyrene increases expression ISO RGD:1331858 6480464 Benzo(a)pyrene results in increased expression of GPHN mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:69477 6480464 7 more ... CTD PMID:19150397 more ... benzo[e]pyrene increases methylation ISO RGD:69477 6480464 benzo(e)pyrene results in increased methylation of GPHN intron CTD PMID:30157460 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GPHN mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1331858 6480464 bisphenol A results in increased expression of GPHN protein CTD PMID:28089772 bisphenol F increases methylation ISO RGD:69477 6480464 bisphenol F results in increased methylation of GPHN gene CTD PMID:31601247 bisphenol F multiple interactions ISO RGD:69477 6480464 [bisphenol F co-treated with Fulvestrant] results in increased methylation of GPHN gene CTD PMID:31601247 bortezomib decreases expression ISO RGD:69477 6480464 Bortezomib results in decreased expression of GPHN mRNA CTD PMID:20977926 cadmium dichloride decreases expression ISO RGD:69477 6480464 Cadmium Chloride results in decreased expression of GPHN mRNA CTD PMID:25596134 caffeine decreases phosphorylation ISO RGD:69477 6480464 Caffeine results in decreased phosphorylation of GPHN protein CTD PMID:35688186 carbamazepine affects expression ISO RGD:69477 6480464 Carbamazepine affects the expression of GPHN mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1331858 6480464 Nanotubes, Carbon results in decreased expression of GPHN mRNA CTD PMID:25620056 casticin decreases expression ISO RGD:1331858 6480464 casticin results in decreased expression of GPHN mRNA CTD PMID:28444820 cerium trichloride increases expression ISO RGD:1331858 6480464 cerous chloride results in increased expression of GPHN mRNA CTD PMID:23573234 chloroacetaldehyde decreases expression ISO RGD:69477 6480464 chloroacetaldehyde results in decreased expression of GPHN mRNA CTD PMID:25596134 cisplatin decreases expression ISO RGD:69477 6480464 Cisplatin results in decreased expression of GPHN mRNA CTD PMID:19561079 , PMID:25596134 cisplatin increases expression ISO RGD:69477 6480464 Cisplatin results in increased expression of GPHN mRNA CTD PMID:27392435 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of GPHN mRNA CTD PMID:17602206 cocaine increases phosphorylation EXP 6480464 Cocaine results in increased phosphorylation of GPHN protein CTD PMID:32312805 cocaine multiple interactions EXP 6480464 (3R)-((2 more ... CTD PMID:32312805 coumarin affects phosphorylation ISO RGD:69477 6480464 coumarin affects the phosphorylation of GPHN protein CTD PMID:35688186 curcumin affects expression EXP 6480464 Curcumin affects the expression of GPHN mRNA CTD PMID:18539377 cyclosporin A decreases expression ISO RGD:69477 6480464 Cyclosporine results in decreased expression of GPHN mRNA CTD PMID:20106945 cyclosporin A increases expression ISO RGD:69477 6480464 Cyclosporine results in increased expression of GPHN mRNA CTD PMID:25562108 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of GPHN mRNA CTD PMID:25596134 dioxygen decreases expression ISO RGD:69477 6480464 Oxygen deficiency results in decreased expression of GPHN mRNA CTD PMID:25596134 dioxygen multiple interactions ISO RGD:1331858 6480464 Oxygen deficiency results in decreased expression of and affects the localization of GPHN protein CTD PMID:29107683 doxorubicin decreases expression ISO RGD:69477 6480464 Doxorubicin results in decreased expression of GPHN mRNA CTD PMID:29803840 endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of GPHN mRNA CTD PMID:29391264 enzyme inhibitor multiple interactions ISO RGD:69477 6480464 [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of GPHN protein CTD PMID:23301498 ethanol increases expression EXP 6480464 Ethanol results in increased expression of GPHN mRNA CTD PMID:15353170 ethanol multiple interactions ISO RGD:1331858 6480464 Ethanol affects the expression of and affects the splicing of GPHN mRNA CTD PMID:30319688 fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of GPHN mRNA CTD PMID:25596134 fenofibrate increases expression ISO RGD:69477 6480464 Fenofibrate results in increased expression of GPHN mRNA CTD PMID:25596134 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of GPHN mRNA CTD PMID:24793618 fulvestrant multiple interactions ISO RGD:69477 6480464 [bis(4-hydroxyphenyl)sulfone co-treated with Fulvestrant] results in decreased methylation of GPHN gene, [bisphenol F co-treated with Fulvestrant] results in increased methylation of GPHN gene CTD PMID:31601247 fulvestrant increases methylation ISO RGD:69477 6480464 Fulvestrant results in increased methylation of GPHN gene CTD PMID:31601247 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of GPHN mRNA CTD PMID:24136188 Heliotrine decreases expression ISO RGD:69477 6480464 heliotrine results in decreased expression of GPHN mRNA CTD PMID:26100227 irinotecan decreases expression EXP 6480464 Irinotecan results in decreased expression of GPHN mRNA CTD PMID:20097248 ivermectin decreases expression ISO RGD:69477 6480464 Ivermectin results in decreased expression of GPHN protein CTD PMID:32959892 metformin increases expression EXP 6480464 Metformin results in increased expression of GPHN mRNA CTD PMID:25596134 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of GPHN mRNA CTD PMID:30467583 methapyrilene increases methylation ISO RGD:69477 6480464 Methapyrilene results in increased methylation of GPHN intron CTD PMID:30157460 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of GPHN gene CTD PMID:23303685 N-methyl-D-aspartic acid multiple interactions ISO RGD:1331858 6480464 N-Methylaspartate inhibits the reaction [gelsenicine results in increased phosphorylation of GPHN protein] CTD PMID:34389372 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of GPHN mRNA more ... CTD PMID:17602206 , PMID:25374375 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of GPHN mRNA CTD PMID:19638242 nickel sulfate decreases expression ISO RGD:69477 6480464 nickel sulfate results in decreased expression of GPHN mRNA CTD PMID:22714537 O-methyleugenol decreases expression ISO RGD:69477 6480464 methyleugenol results in decreased expression of GPHN mRNA CTD PMID:32234424 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GPHN mRNA CTD PMID:25729387 paracetamol affects expression ISO RGD:1331858 6480464 Acetaminophen affects the expression of GPHN mRNA CTD PMID:17562736 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of GPHN mRNA, [Diethylnitrosamine co-treated with Phenobarbital] results in increased methylation of GPHN promoter CTD PMID:25374375 pirinixic acid multiple interactions ISO RGD:69477 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPHN mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1331858 6480464 pirinixic acid results in decreased expression of GPHN mRNA CTD PMID:18445702 potassium chromate decreases expression ISO RGD:69477 6480464 potassium chromate(VI) results in decreased expression of GPHN mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:69477 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of GPHN mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO RGD:1331858 6480464 Potassium Dichromate results in decreased expression of GPHN mRNA CTD PMID:23608068 senecionine decreases expression ISO RGD:69477 6480464 senecionine results in decreased expression of GPHN mRNA CTD PMID:26100227 Senkirkine decreases expression ISO RGD:69477 6480464 senkirkine results in decreased expression of GPHN mRNA CTD PMID:26100227 sevoflurane increases expression ISO RGD:1331858 6480464 Sevoflurane results in increased expression of GPHN mRNA, Sevoflurane results in increased expression of GPHN protein CTD PMID:30502404 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of GPHN protein CTD PMID:19072884 sodium dichromate decreases expression EXP 6480464 sodium bichromate results in decreased expression of GPHN mRNA CTD PMID:25993096 sunitinib increases expression ISO RGD:69477 6480464 Sunitinib results in increased expression of GPHN mRNA CTD PMID:31533062 testosterone decreases expression ISO RGD:69477 6480464 Testosterone results in decreased expression of GPHN mRNA CTD PMID:33359661 tetrachloromethane affects expression ISO RGD:1331858 6480464 Carbon Tetrachloride affects the expression of GPHN mRNA CTD PMID:17484886 tetrachloromethane decreases expression ISO RGD:1331858 6480464 Carbon Tetrachloride results in decreased expression of GPHN mRNA CTD PMID:27339419 , PMID:31919559 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of GPHN mRNA CTD PMID:23411599 , PMID:34492290 toluene affects expression EXP 6480464 Toluene affects the expression of GPHN mRNA CTD PMID:21827849 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of GPHN mRNA CTD PMID:25729387 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of GPHN mRNA CTD PMID:25729387 troglitazone decreases expression ISO RGD:1331858 6480464 troglitazone results in decreased expression of GPHN mRNA CTD PMID:28973697 trovafloxacin decreases expression ISO RGD:1331858 6480464 trovafloxacin results in decreased expression of GPHN mRNA CTD PMID:35537566 urethane increases expression ISO RGD:69477 6480464 Urethane results in increased expression of GPHN mRNA CTD PMID:28818685 valproic acid increases expression ISO RGD:69477 6480464 Valproic Acid results in increased expression of GPHN mRNA CTD PMID:23179753 , PMID:29154799 valproic acid affects expression ISO RGD:69477 6480464 Valproic Acid affects the expression of GPHN mRNA CTD PMID:25979313 WIN 55212-2 multiple interactions EXP 6480464 (3R)-((2 more ... CTD PMID:32312805